The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Åke Borg

Åke Borg

Principal investigator

Åke Borg

Molecular profiling reveals low- and high-grade forms of primary melanoma


  • Katja Harbst
  • Johan Staaf
  • Martin Lauss
  • Anna Karlsson
  • Anna Måsbäck
  • Iva Johansson
  • Pär-Ola Bendahl
  • Johan Vallon-Christersson
  • Therese Törngren
  • Henrik Ekedahl
  • Jurgen Geisler
  • Mattias Höglund
  • Markus Ringnér
  • Lotta Lundgren
  • Karin Jirström
  • Håkan Olsson
  • Christian Ingvar
  • Åke Borg
  • Hensin Tsao
  • Göran B Jönsson

Summary, in English


For primary melanomas, tumor thickness, mitotic rate and ulceration are well-laid cornerstones of prognostication. However, a molecular exposition of melanoma aggressiveness is critically missing. We recently uncovered a four-class structure in metastatic melanoma that predicts outcome and informs biology. This raises the possibility that a molecular structure exists even in the early stages of melanoma and that molecular determinants could underlie histophenotype and eventual patient outcome. Experimental design: We subjected 223 archival primary melanomas to a horizontally-integrated analysis of RNA expression, oncogenic mutations at 238 lesions, histomorphometry and survival data.


Our previously described four-class structure that was elucidated in metastatic lesions was evident within the expression space of primary melanomas. Since these subclasses converged into two larger prognostic and phenotypic groups, we used the metastatic lesions to develop a binary subtype-based signature capable of distinguishing between "high" and "low" grade forms of the disease. The two-grade signature was subsequently applied to the primary melanomas. Compared to low-grade tumors, high-grade primary melanomas were significantly associated with increased tumor thickness, mitotic rate, ulceration (all P less than 0.01) and poorer relapse-free (HR=4.94; 95%CI 2.84-8.59) and overall (HR=3.66; 95%CI 2.40-5.58) survival. High-grade melanomas exhibited elevated levels of proliferation and BRCA1/DNA damage signaling genes while low-grade lesions harbored higher expression of immune genes. Importantly, the molecular grade signature was validated in two external gene expression datasets.


We provide evidence for a molecular organization within melanomas that is preserved across all stages of disease.


  • Breastcancer-genetics
  • Tumor microenvironment
  • Surgery (Lund)
  • Melanoma Genomics
  • EpiHealth: Epidemiology for Health
  • BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation

Publishing year







Clinical Cancer Research





Document type

Journal article


American Association for Cancer Research


  • Cancer and Oncology



Research group

  • Melanoma Genomics


  • ISSN: 1078-0432